Maureen Curran Email

VP, Pharmacovigilance and Risk Management . Angion Biomedica Corp

Current Roles

Employees:
23
Revenue:
$2.8M
About
We are a late-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases. Our goal is to transform the treatment paradigm for patients suffering from these potentially life-threatening conditions for which there are no approved medicines or where existing approved medicines have limitations.
Angion Biomedica Corp Address
51 Charles Lindbergh Boulevard
Uniondale, NY
United States
Angion Biomedica Corp Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.